Episode 51: The State of Sleep Medicine

Episode 51 of the NeurologyLive^® Mind Moments™ podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments™ podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.

Episode 51, "The State of Sleep Medicine," features an exclusive interview with Karl Doghramji, MD, FAASM, DFAPA, professor of psychiatry and human behavior; professor of neurology; and medical director, Jefferson Sleep Disorders Center, at the Vickie and Jack Farber Institute for Neuroscience of Jefferson Health. He shared his perspective on the current state of care for sleep disorders, the impact of the pandemic on sleep in the US, and some of the recent advances in therapeutics and research.

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

• Phase 3 PHOENIX Study of AMX0035 in ALS Gets Under Way
• FDA Approves First Oral Solution of Topiramate to Treat Epilepsy, Migraines
• Robert Califf, MD, Nominated by Biden Administration as Next FDA Commissioner

Click here to subscribe to the Mind Moments™ podcast. Be sure to leave a rating and review for the show. Thanks for listening!